Literature DB >> 26991036

Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.

Simone Frea1, Stefano Pidello1, Virginia Bovolo1, Cristina Iacovino1, Erica Franco2, Francesco Pinneri2, Alessandro Galluzzo1, Alessandra Volpe1, Massimiliano Visconti1, Andrea Peirone1, Mara Morello1, Serena Bergerone1, Fiorenzo Gaita1.   

Abstract

AIMS: The purpose of this study was to evaluate the additional prognostic value of echocardiography in acute decompensation of advanced chronic heart failure (CHF), focusing on right ventricular (RV) dysfunction and its interaction with loading conditions. Few data are available on the prognostic role of echocardiography in acute HF and on the significance of pulmonary hypertension in patients with severe RV failure. METHODS AND
RESULTS: A total of 265 NYHA IV patients admitted for acute decompensation of advanced CHF (EF 22 ± 7%, systolic blood pressure 107 ± 20 mmHg) were prospectively enrolled. Fifty-nine patients met the primary composite endpoint of cardiac death, urgent heart transplantation, and urgent mechanical circulatory support implantation at 90 days. Pulmonary hypertension failed to predict events, while patients with a low transtricuspid systolic gradient (TR gradient <20 mmHg) showed a worse outcome [hazard ratio (HR) 2.37, 95% confidence interval (CI) 1.12-5.00, P = 0.02]. RV dysfunction [tricuspid annular plane systolic excursion (TAPSE) ≤14 mm] in the presence of a low TR gradient identified patients at higher risk of events (HR 2.97, 95% CI 1.19-7.41, P = 0.02). Multivariate analysis showed as best predictors of outcome low RV contraction pressure index (RVCPI), defined as TAPSE × TR gradient, and high estimated right atrial pressure (eRAP). Adding RVCPI (<400 mm*mmHg) and eRAP (≥20 mmHg) to conventional clinical (ADHERE risk tree and NT-proBNP) and echocardiographic risk evaluation resulted in an increase in net reclassification improvement of +19.1% and +20.1%, respectively (P = 0.01) and in c-statistic from 0.59 to 0.73 (P < 0.01).
CONCLUSIONS: In acute decompensation of advanced CHF, pulmonary hypertension failed to predict events. The in-hospital and short-term prognosis can be better predicted by eRAP and RVCPI.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Acute heart failure; Advanced chronic heart failure; Echocardiography; Pulmonary pressure; Right atrial pressure; Right ventricle

Mesh:

Substances:

Year:  2016        PMID: 26991036     DOI: 10.1002/ejhf.504

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Evaluation of right ventricular function by coronary computed tomography angiography using a novel automated 3D right ventricle volume segmentation approach: a validation study.

Authors:  Philipp Burghard; Fabian Plank; Christoph Beyer; Silvana Müller; Jakob Dörler; Marc-Michael Zaruba; Leo Pölzl; Gerhard Pölzl; Andrea Klauser; Stefan Rauch; Fabian Barbieri; Christian-Ekkehardt Langer; Wilfried Schgoer; Eric E Williamson; Gudrun Feuchtner
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

Review 2.  Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.

Authors:  Marco Guazzi; Valentina Labate
Journal:  Curr Heart Fail Rep       Date:  2016-12

3.  The Combination of Tricuspid Annular Plane Systolic Excursion and HeartMate Risk Score Predicts Right Ventricular Failure After Left Ventricular Assist Device Implantation.

Authors:  David S Raymer; Jonathan D Moreno; Marc A Sintek; Michael E Nassif; Christopher T Sparrow; Luigi Adamo; Eric L Novak; Shane J LaRue; Justin M Vader
Journal:  ASAIO J       Date:  2019 Mar/Apr       Impact factor: 2.872

4.  Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.

Authors:  Simone Frea; Stefano Pidello; Alessandra Volpe; Federico Giovanni Canavosio; Alessandro Galluzzo; Virginia Bovolo; Antonio Camarda; Pier Giorgio Golzio; Fabrizio D'Ascenzo; Serena Bergerone; Mauro Rinaldi; Fiorenzo Gaita
Journal:  Clin Res Cardiol       Date:  2019-06-29       Impact factor: 5.460

5.  Right atrial volume index to left atrial volume index ratio is associated with adverse clinical outcomes in cardiogenic shock.

Authors:  Paras R Patel; Patrick L Stafford; Kenneth C Bilchick; McCall R Walker; Sami Ibrahim; David Martin; Yaqub Betz; Toral R Patel; Younghoon Kwon; Nishaki Mehta; Nishtha Sodhi; Hunter Mwansa; Khadijah Breathett; Sula Mazimba
Journal:  J Echocardiogr       Date:  2021-10-08

6.  Temporary assist device support for the right ventricle: pre-implant and post-implant challenges.

Authors:  Michael Dandel; Roland Hetzer
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

7.  Long-term performance of untreated fresh autologous pericardium as a valve substitute in pulmonary position.

Authors:  Shantanu Pande; Amitabh Arya; Surendra K Agarwal; Prabhat Tewari; Aditya Kapoor; Neetu Soni; Sunil Kumar
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

8.  Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.

Authors:  Jacob C Jentzer; Brandon M Wiley; Yogesh N V Reddy; Christopher Barnett; Barry A Borlaug; Michael A Solomon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-03-16

9.  Prognostic Value of Right Ventricular Cardiac Power Output at Rest in Patients with Advanced Heart Failure.

Authors:  Omer Yildiz; Cemal Deniz Yenigun
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

Review 10.  Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Authors:  Emmanuelle Berthelot; Fabrice Bauer; Jean-Christophe Eicher; Erwan Flécher; Barnabas Gellen; Julien Guihaire; Damien Guijarro; Gérald Roul; Muriel Salvat; Christophe Tribouilloy; Florian Zores; Nicolas Lamblin; Pascal de Groote; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2018-07-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.